 |
Sunday, October 31, 2010
Decrease in the Company Stock Price Medifast Weight Loss Drug Makers
11:02 PM | 
Posted by
sukirnoMedifast Weight Loss
Arena Pharmaceuticals stock has fallen almost 4% over last year for her medication. Orexigen stock has fallen 21% over last year, to close Friday at $ 4.17, marking a significant decline from the June 2007 peak of $ 17.70 per share.
Decision Resources, a drug industry analysis firm, believes that the three drugs are expected to win approval and find a place in the global obesity market. The company expects the global market to soar from $ 500 million to 3.4 billion U.S. dollars in 2018.
Investors clearly support Vivus in three-way race. Vivus shares had nearly doubled over last year to close Friday at $ 11.52.
While Arena's drug traces its competitors in weight loss, appears to have minimal side effects, an important factor in FDA approval.
What is truly novel drug that FDA reportedly showed the weakest results in clinical trials. lorcaserin Arena Pharmaceuticals' is the first-a-kind drugs that act on serotonin, a brain chemical associated with feelings of well-being and burnout. But patients in the trial the company lost only 5% of their weight.
"We use a combination of old drugs with a very broad spectrum of pharmacotherapy, the approach is very much worth it," said Halford, a health psychologist.
Two years ago Sanofi-Aventis SA terminated the highly anticipated study of Acomplia pill because of side effects people, including depression and suicidal thoughts.
Side effects save a small amount of weight loss drugs on the market from being a blockbuster seller. appetite Abbott Laboratories' Meridia suppressor withdrawn from the market in Europe last November because of data showing increased risk of heart attack. And in May, the FDA warned consumers that the weight of over-the-counter pill alli losses, which have been sold for years with high dose as the prescription drug Xenical, it can cause serious liver damage.
Derek Lowe, a pharmaceutical researcher and blogger, said the new combination of drugs were reported more promising because the drug works on several brain chemicals that eventually even encourage overeating.
What is truly novel drug that FDA reportedly showed the weakest results in clinical trials. lorcaserin Arena Pharmaceuticals' is the first-a-kind drugs that act on serotonin, a brain chemical associated with feelings of well-being and burnout. But patients in the trial the company lost only 5% of their weight.
"We use a combination of old drugs with a very broad spectrum of pharmacotherapy, the approach is very much worth it," said Halford, a health psychologist.
Two years ago Sanofi-Aventis SA terminated the highly anticipated study of Acomplia pill because of side effects people, including depression and suicidal thoughts.
Side effects save a small amount of weight loss drugs on the market from being a blockbuster seller. appetite Abbott Laboratories' Meridia suppressor withdrawn from the market in Europe last November because of data showing increased risk of heart attack. And in May, the FDA warned consumers that the weight of over-the-counter pill alli losses, which have been sold for years with high dose as the prescription drug Xenical, it can cause serious liver damage.
Derek Lowe, a pharmaceutical researcher and blogger, said the new combination of drugs were reported more promising because the drug works on several brain chemicals that eventually even encourage overeating.
By. Medifast Weight Loss
Subscribe to:
Post Comments (Atom)
1 comments:
good info, very helpful
keep in touch: Mesothelioma Information
Post a Comment